Form 4: Corcept Therapeutics Executive William Guyer Exercises Options and Sells Shares
SEC Form 4 Filing
William Guyer, Chief Development Officer of Corcept Therapeutics, exercised stock options and sold 10,000 shares of common stock on July 1, 2024, according to a recent SEC filing.
Summary
- On July 1, 2024, William Guyer, the Chief Development Officer of Corcept Therapeutics, exercised stock options to acquire 10,000 shares of common stock at a price of $21.65 per share.
- Simultaneously, Guyer sold 10,000 shares of Corcept Therapeutics common stock at a price of $32.49 per share.
- Following these transactions, Guyer directly owns 6,039 shares of Corcept Therapeutics common stock.
- He also holds options to purchase 490,000 shares.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions, which is neutral in sentiment.
Industry Context
This filing is a routine disclosure of insider transactions. It's common for executives to exercise stock options and sell a portion of the acquired shares for personal financial management.
Comparison to Industry Standards
- Executive compensation packages often include stock options as incentives.
- The vesting schedules and exercise prices are typical for the pharmaceutical industry.
- Comparing Guyer's holdings and transactions to those of executives at similar-sized biotech companies like Exelixis or Incyte would provide further context.
Stakeholder Impact
- The transaction could have a minor impact on shareholders, depending on how the market interprets the insider sale.
- The sale was executed under a pre-arranged 10b5-1 trading plan.
Key Dates
| Date | Description |
|---|---|
| 08/16/2021 | Vesting Commencement Date for stock options |
| 09/01/2023 | Date of restricted stock awards grant |
| 12/01/2023 | Date of restricted stock units grant |
| 07/01/2024 | Date of transaction: Exercise of stock options and sale of shares |
| 07/03/2024 | Date of Form 4 filing |
| 09/01/2031 | Expiration date of stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.